The Arkansas Pharmacists Association and Attorney General Tim Griffin held a press conference at 10:30 a.m. Thursday regarding statewide pharmacy benefit manager reform legislation.
Sean O'Driscoll is a Newsweek Senior Crime and Courts Reporter based in Ireland. His focus is reporting on U.S. law. He has covered human rights and extremism extensively. Sean joined Newsweek in ...
“Last year, our PBM passed through more than 98% of the rebate discounts we negotiate with drug companies to our clients,” he said. “While we offer customers 100% pass-through ...
On Tuesday, the U.S. Federal Trade Commission (FTC) presented evidence that UnitedHealth Group’s OptumRx, along with its two main competitors, Express Scripts and CVS Caremark Rx, inflated the ...
FTC Chair Lina Khan has the big three pharmacy benefit managers in sight—UnitedHealth's OptumRx, Cigna's Express Scripts and CVS Caremark Rx. © 2024 Fortune Media ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs. A new report by the Federal Trade Commission ...
The study—authorized by the three Democratic and two Republican commissioners—involved pharmacy benefit management firms Express Scripts, OptumRx and Caremark. In a 45-page administrative ...
The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.
The price concessions from the pharmacy come from lower contracted rates that pharmacies must accept in order to participate in the PBM’s pharmacy network. Depending on the way an employer ...
Hosted on MSN22d
'Big 3' pharmacy benefit managers marked up drugs by $7.3B: FTCThe three biggest pharmacy benefit managers marked up "lifesaving" medications to generate $7.3 billion in five years, according to the FTC. Kohl's cuts 10% of corporate workforce weeks after ...
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in many prescription drug transactions, say they help keep costs from ...
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare and commercial claims alike. Tuesday, the U.S. Federal Trade Commission ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback